References
- Andersen B, Krøger E, Roberts R.G. Chemical and morphological segregation of Alternaria arborescens, A. infectoria and A. tenuissima species-group. Mycolog Res 2002; 106: 170–182
- de Hoog, GS, Guarro, J. Atlas of Clinical Fungi. Centraalbureau voor Schimmelcultures, Baarn, The Netherlands.
- White TJ, Burns S, Taylor L. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protocols: A Guide to Methods and Applications, N Innis, J Gelfand, T White. Academic Press, New York 1990; 315–322
- NCCLS. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. NCCLS document M38-A. NCCLS: Wayne, PA, 2002.
- Chabasse D. Les Phaéohyphomycètes agents de phaéohyphomycoses: des champignons émergents. J Mycol Med 2002; 12: 65–85
- Ferrer C, Montero J, Alio JL, et al. Rapid molecular diagnosis of posttraumatic keratitis and endophthalmitis caused by Alternaria infectoria. J Clin Microbiol 2003; 41: 3358–3360
- Gerdsen R, Uerlich M, De Hoog G S, et al. Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol 2001; 145: 484–486
- Halaby T, Boots H, Vermeulen A, et al. Phaeohyphomycosis caused by Alternaria infectoria in a renal transplant recipient. J Clin Microbiol 2001; 39: 1952–1955
- Lo Cascio G, Ligozzi M, Maccacaro L, et al. Utility of molecular identification in opportunistic infections: a case of cutaneous Alternaria infectoria infection in a cardiac transplant patient. J Clin Microbiol 2004; 42: 5334–5336
- Guarro J, Gené J, Stchigel AM. Development in fungal taxonomy. Clin Microbiol Rev 1999; 12: 454–500
- Lyke KE, Miller NS, Towne L, et al. A case of cutaneous ulcerative alternariosis: rare association with diabetes mellitus and unusual failure of itraconazole treatment. Clin Infect Dis 2001; 32: 1178–1187
- Revankar SG, Patterson JE, Sutton D, et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34: 467–476
- Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684
- Pereiro M, Jr, Pereiro Ferreir o˘s MM, De Hoog GS, et al. Cutaneous infection caused by Alternaria in patients receiving tacrolimus. Med Mycol 2004; 42: 277–282
- De Hoog GS, Horré R. Molecular taxonomy of the Alternaria and Ulocladium species from humans and their identification in the routine laboratory. Mycoses 2002; 45: 259–276
- Iwen PC, Hinrichs H, Rupp ME. Utilisation of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol 2002; 40: 87–109
- Roberts RG, Reymond ST, Andersen B. RAPD fragment pattern analysis and morphological segregation of small-spored Alternaria species and species groups. Mycolog Res 2000; 104: 1312–1321
- Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954–958
- Pujol I, Aguilar C., Gené, Guarro J. In vitro antifungal susceptibility of Alternaria spp. and Ulocladium spp. J Antimiocrob Chemother 2000; 46: 323–342
- Laumaillé C, Le Gall F, Degeilh B, et al. Infection cutanée à Alternaria infectoria après greffe hépatique. Ann Pathol 1998; 18: 192–194